Letter From the Editor

June 2018

Dear Colleague,

As the number of treatment options for hematologic malignancies continues to grow, so does the list of potential side effects resulting from these evolving therapies. It is imperative that we continue educating ourselves on recognizing and properly managing them.

To further the conversation on this important topic, we’ve created Updates for the Advanced Practitioner in Oncology: Side-Effect Management for Hematologic Malignancies. This educational newsletter and website contain news and research articles highlighting the latest in management strategies. In our next edition, we’ll present an upcoming video roundtable discussion I’m holding with three expert colleagues on pressing issues in this area.

Through this initiative, we hope to spur discussion among advanced practitioners and equip you with practical strategies for managing the various adverse effects of therapy for hematologic malignancies—all in an effort to optimize patient outcomes and improve clinical approach.

Be on the lookout for our next edition in the coming months, and in the meantime, feel free to share this valuable resource with your colleagues. You can also contact me with comments or suggestions at any time through the JADPRO editors at editor@advancedpractitioner.com.

Allyson Price, MPAS, PA-C
Physician Assistant, Department of Leukemia
University of Texas MD Anderson Cancer Center


View past letters →